Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InfuSystem Holdings ( (INFU) ) has issued an update.
InfuSystem Holdings, Inc., a national healthcare service provider focused on outpatient care for complex durable medical equipment, operates through Patient Services in oncology, pain management and wound therapy, and a Device Solutions segment providing rentals, equipment sales and biomedical services. The company is headquartered in Rochester Hills, Michigan, with Centers of Excellence across several U.S. states and in Ontario, Canada.
On February 17, 2026, InfuSystem announced it would release its preliminary fourth-quarter and full-year 2025 financial results before the market opens on February 24, 2026. The company also scheduled an investor conference call for the same day at 9:00 a.m. Eastern Time to discuss the results, signaling upcoming disclosure that may shape investor expectations around its recent operating and financial performance.
The most recent analyst rating on (INFU) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.
Spark’s Take on INFU Stock
According to Spark, TipRanks’ AI Analyst, INFU is a Neutral.
InfuSystem Holdings shows strong financial performance and strategic growth initiatives, particularly in Oncology and Wound Care. However, technical indicators suggest bearish momentum, and the high P/E ratio indicates potential overvaluation. Recent corporate events, including CMS approval, provide a positive outlook for future growth.
To see Spark’s full report on INFU stock, click here.
More about InfuSystem Holdings
InfuSystem Holdings, Inc., listed on the NYSE American as INFU, is a national healthcare service provider that facilitates outpatient care for durable medical equipment manufacturers and healthcare providers. Operating under a two-platform model, it offers Patient Services in oncology, pain management and wound therapy, and Device Solutions including rentals, pump and consumable sales, and biomedical services and repair.
The company, headquartered in Rochester Hills, Michigan, delivers local field-based customer support and runs Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. Its Patient Services platform focuses on last-mile clinic-to-home care involving complex durable medical equipment, while Device Solutions supports that platform and targets incremental business from direct payer clients.
Average Trading Volume: 130,647
Technical Sentiment Signal: Strong Sell
Current Market Cap: $153.3M
For detailed information about INFU stock, go to TipRanks’ Stock Analysis page.